GeggelRL, ReidLM. The structural basis of PPHN (review). Clin Perinatol1984;11(3):525–549.
5.
RobertsJDJr, ShaulPW. Advances in the treatment of persistent pulmonary hypertension of the newborn (review). Pediatr Clin North Am1993;40(5):983–1004.
RobertsJDJr, ChenTY, KawaiN, WainJ, DupuyP, ShimouchiA, et al. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res1993;72(2):246–254.
8.
ZayekM, ClevelandD, MorinFC3rd. Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. J Pediatr1993;122(5 Pt 1):743–750.
9.
ZayekM, WildL, RobertsJDJr, MorinFC3rd. Effect of nitric oxide on the survival rate and incidence of lung injury in newborn lambs with persistent pulmonary hypertension. J Pediatr1993;123(6):947–952.
10.
BergerJI, GibsonRL, ReddingGJ, StandaertTA, ClarkeWR, TruogWE. Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. Am Rev Respir Dis1993;147(5):1080–1086.
11.
BarringtonKJ, FinerNN, PeliowskiA, EtchesPC, GrahamAJ, ChanWK. Inhaled nitric oxide improves oxygenation in piglets with meco-nium aspiration. Pediatr Pulmonol1995;20(1):27–33.
12.
KaramanoukianHL, GlickPL, ZayekM, SteinhornRH, ZwassMS, FinemanJR, MorinFC3rd. Inhaled nitric oxide in congenital hyp-oplasia of the lungs due to diaphragmatic hernia or oligohydramnios. Pediatrics1994;94(5):715–718.
13.
WilcoxDT, GlickPL, KaramanoukianHL, MorinFC3rd, FuhrmanBP, LeachC.Partial liquid ventilation and nitric oxide in congenital diaphragmatic hernia. J Pediatr Surg1997;32(8):1211–1215.
14.
RoviraI, ChenTY, WinklerM, KawaiN, BlochKD, ZapolWM. Effects of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J App Physiol1994;76(1):345–355.
15.
KrauseMF, LienhartHG, HaberstrohJ, HoehnT, Schulte-MontingJ, LeititisJU. Effect of inhaled nitric oxide on intrapulmonary right-to-left-shunting in two rabbit models of saline lavage induced sur-factant deficiency and meconium instillation. Eur J Pediatr1998;157(5):410–415.
16.
RobertsJDJr, PolanerDM, LangP, ZapolWM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet1992;340(8823):818–819.
17.
KinsellaJP, McQuestonJA, RosenbergAA, AbmanSH. Hemody-namic effects of exogenous nitric oxide in ovine transitional pulmo-nary circulation. Am J Physiol1992;263(3 Pt 2):H875–H880.
18.
FinerNN, EtchesPC, KamstraB, TierneyAJ, PeliowskiA, RyanCA. Inhaled nitric oxide in infants referred for extracorporeal mem-brane oxygenation: dose response. J Pediatr1994;124(2):302–308.
19.
RobertsJDJr, FinemanJR, MorinFC3rd, ShaulPW, RimarS, SchreiberMD, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med1997;336(9):605–610.
20.
DavidsonD, BarefieldES, KattwinkelJ, DudellG, DamaskM, StraubeR, et al. Inhaled nitric oxide for the early treatment of per-sistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group. Pediatrics1998;101(3 Pt 1):325–334.
21.
KinsellaJP, TruogWE, WalshWF, GoldbergRN, BancalariE, MayockDE, et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr1997;131(1 Pt 1):55–62.
22.
The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med1997;336(9):597–604.
23.
CrawleyDE, ZhaoL, GiembyczMA, LiuS, BarnesPJ, WinterRJD, EvansTW. Chronic hypoxia impairs soluble guanylyl cyclase-me-diated pulmonary arterial relaxation in the rat. Am J Physiol1992;263(3 Pt 1):L325–L332.
24.
SteinhornRH, RussellJA, MorinFC3rd. Disruption of cGMP production in pulmonary arteries isolated from fetal lambs with pulmo-nary hypertension. Am J Physiol1995;268(4 Pt 2):H1483–H1489.
25.
McQuestonJA, KinsellaJP, IvyDD, McMurtryIF, AbmanSH. Chronic pulmonary hypertension in utero impairs endothelium-de-pendent vasodilation. Am J Physiol1995;268(1 Pt 2):H288–H294.
26.
IchinoseF, AdrieC, HurfordWE, ZapolWM. Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs. J App Physiol1995;78(2):1288–1295.
KinsellaJP, TorielliF, ZieglerJW, IvyDD, AbmanSH. Dipyrid-amole augmentation of response to nitric oxide (letter). Lancet1995;346(8975):647–648.
29.
KinsellaJP, AbmanSH. High-frequency oscillatory ventilation aug-ments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: Nitric Oxide Study Group. Chest1998;114(1 Suppl):100S.
30.
The Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics1997;99(6):838–845.
31.
ReidL.The lung: growth and remodeling in health and disease. Am J Roentgenol1977;129:777–788.
32.
HislopA, ReidL.Changes in the pulmonary arteries of the rat during recovery from hypoxia-induced pulmonary hypertension. Br J Exp Pathol1977;58:653–662.
33.
MeyrickB, ReidL.The effect of continued hypoxia on rat pulmo-nary arterial circulation. An ultrastructural study. Lab Invest1978;38(2):188–200.
34.
RabinovitchM, GambleWJ, NadasAS, MiettinenOS, ReidL.Rat pulmonary circulation after chronic hypoxia: hemodynamic and struc-tural features. Am J Physiol1979;236(6):H818–H827.
35.
KouyoumdjianC, AdnotS, LevameM, EddahibiS, BousbaaH, RaffestinB.Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest1994;94(2):578–584.
36.
RobertsJDJr, RobertsCT, JonesRC, ZapolWM, BlochKD. Con-tinuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res1995;76(2):215–222.
37.
KourembanasS, McQuillanLP, LeungGK, FallerDV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin In-vest1993;92(1):99–104.
38.
GargUC, HassidA.Nitric oxide-generating vasodilators and 8-bro-mo-cyclic guanosine monophosphate inhibit mitogenesis and prolif-eration of cultured rat vascular smooth muscle cells. J Clin Invest1989;83(5):1774–1777.
39.
GargUC, HassidA.Mechanisms of nitrosothiol-induced antimito-genesis in aortic smooth muscle cells. Eur J Pharmacol1993;237(2-3):243–249.
40.
RobertsJDJr, ChicheJD, WeimannJ, SteudelW, ZapolWM, BlochKD. Inhaled nitric oxide gas (NO) prevents pulmonary artery neo-muscularization in rat pups without pulmonary artery hypertension. Circulation1998;1:341.
41.
ToddL, MullenM, OlleyPM, RabinovitchM.Pulmonary toxicity of monocrotaline differs at critical periods of lung development. Pediatr Res1985;19(7):731–737.
42.
MaruyamaJ, MaruyamaK, MitaniY, KitabatakeM, YamauchiT, MiyasakaK.Continuous low-dose NO inhalation does not prevent monocrotaline-induced pulmonary hypertension in rats. Am J Physiol1997;272(1 Pt 2):H517–524.
43.
HorstmanDJ, FrankDU, RichGF. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remod-eling in rats. Anesth Analg1998;86(1):74–81.
44.
MitaniY, MaruyamaK, SakuraiM.Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmo-nary vascular remodeling in rats. Circulation1997;96(2):689–697.
45.
TakahashiT, KandaT, InoueM, SuzukiT, KobayashiI, KodamaK, NagaiR.A selective type V phosphodiesterase inhibitor, E4021, protects the development of right ventricular overload and medial thickening of pulmonary arteries in a rat model of pulmonary hy-pertension. Life Sci1996;59(23):PL371–377.
46.
Clutton-BrockJ.Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anesthesia. Br J Anaesth1967;39(5):388–392.
47.
HallmanM, BryK, TurbowR, WaffarnF, LappalainenU.Pulmo-nary toxicity associated with nitric oxide in term infants with severe respiratory failure. J Pediatr1998;132(5):827–829.
48.
KinsellaJP, ParkerTA, GalanH, SheridanBC, HalbowerAC, AbmanSH. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline mem-brane disease. Pediatr Res1997;41(4 Pt 1):457–463.
49.
GeorgeTN, JohnsonKJ, BatesJN, SegarJL. The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr1998;132(4):731–734.
50.
RosenbergAA, KennaughJM, MorelandSG, FashawLM, HaleKA, TorielliFM, et al. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr1997;131(1 Pt 1):70–75.
